PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[midastouch017]

From the PR:
...said Giacomo Chiesi, Head of Chiesi Global Rare Diseases.
"We thank the patients and clinicians participating in our
completed and ongoing clinical studies evaluating PRX-102.
We are continuing to coordinate closely with the FDA to
address and quickly resolve the deficiencies contained
in the CRL."

Deficiencies; plural, not singular



Very perplexing indeed!